glaxosmithkline plc (GSK:London)
Christopher Adam Ph.D.
Director of Commercial Strategy, GlaxoSmithKline plc
|Age||Total Calculated Compensation||This person is connected to 28 board members in 3 different organizations across 4 different industries.|
See Board Relationships
Mr. Christopher Adam, Ph.D., Chris is the Managing Director of GlaxoWellcome KK, Japan. Mr. Adam served as President of French organization at Glaxo, as Regional Director of Japan since 1997 and was also a global board member of GlaxoWellcome. He has over 35 years of board level and operational experience in the pharmaceutical industry, including executive roles in the mergers of Glaxo with Wellcome, and in the acquisition of biotechs such as Affymax. He served as President ...
980 Great West RoadPhone: 44 20 8047 5000
Brentford, Middlesex TW8 9GS
Board Members Memberships*
University College London
Stanford Graduate School of Business
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Robert A. Bradway||Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee|
|Lamberto Andreotti||Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee|
Bristol-Myers Squibb Company
|Inge G. Thulin||Chairman, Chief Executive Officer and President|
|Lars Rebien Sørensen||Chief Executive Officer and Member of Executive Management|
Novo Nordisk A/S
|Serge Weinberg||Chairman, Interim Chief Executive Officer, Chairman of Appointments & Governance Committee and Chairman of Strategy Committee|
|€700.0K||Compensation as of Fiscal Year 2013.|